MedPath

clinical study using siddha medicine for Atopic dermatitis

Phase 2
Conditions
Health Condition 1: L209- Atopic dermatitis, unspecified
Registration Number
CTRI/2024/07/071212
Lead Sponsor
Government Siddha Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Itching

Erythema

Papules

Vesicles

Oozing

Crusting

Scaling

Lichenification

Exclusion Criteria

Psoriasis

Scabies

Photo dermatitis

Ichthyosis vulgaris

Pityriasis alba

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in EASI score(Eczema Area Severity Index) <br/ ><br>Reduction in clinical symptoms like itching,papules,pustules, <br/ ><br>Oozing,scaling,lichenificationTimepoint: 10 Days
Secondary Outcome Measures
NameTimeMethod
It is assessed by comparing the safety parameters before and after treatmentTimepoint: 10 Days
© Copyright 2025. All Rights Reserved by MedPath